account_balance
Investment manager · 13F filer · SEC CIK 1825034
Euclidean Capital LLC
Reported value$440Mas of Jun 30, 2026
Positions11 1 new, 0 sold out
Top 10 weight100.0%VEU alone is 62%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
This fund reports 11 stocks.
VEUVanguard Intl Equity Index F
61.8%
VTVVanguard Index FDS
25.8%
INDAiShares Tr
4.2%
ORICOric Pharmaceuticals Inc
2.4%
TMSTeamshares Inc
2.1%New
FHTXFoghorn Therapeutics Inc
1.7%
PMVP0.8%ALEC0.6%SRZNTNYABox size is the share of the fund. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 11 as a list
VEU Vanguard Intl Equity Index F 61.8% Held
VTV Vanguard Index FDS 25.8% Held
INDA iShares Tr 4.2% Held
ORIC Oric Pharmaceuticals Inc 2.4% HeldTMS Teamshares Inc 2.1% NewFHTX Foghorn Therapeutics Inc 1.7% HeldPMVP PMV Pharmaceuticals Inc 0.8% HeldALEC Alector Inc 0.6% HeldSRZN Surrozen Inc 0.5% HeldTNYA Tenaya Therapeutics Inc 0.2% HeldSurrozen Inc 0.0% Held
What changed